{"id":3705,"date":"2019-01-17T16:09:33","date_gmt":"2019-01-17T21:09:33","guid":{"rendered":"https:\/\/www.bu.edu\/amyloid\/?page_id=3705"},"modified":"2019-11-20T16:28:29","modified_gmt":"2019-11-20T21:28:29","slug":"2019-2","status":"publish","type":"page","link":"https:\/\/www.bu.edu\/amyloid\/2019-2\/","title":{"rendered":"2019"},"content":{"rendered":"
Staron A, Kataria Y, Murray D, Sloan J.M, Sanchorawala V.<\/strong>\u00a0 Systemic AL amyloidosis with an undetectable plasma cell dyscrasia: a zebra without stripes.<\/a>\u00a0American Journal of Hematology. 17 Nov 2019.<\/p>\n

Sarosiek S, Sanchorawala V.<\/strong> Treatment Options for Relapsed\/Refractory Systemic Light-Chain (AL) Amyloidosis: Current Perspectives. J Blood Med. 2019 Oct 23; 10:373-380. View in PubMed<\/a><\/p>\n

Elliot J, Zhou L, Chunyu C and Kaku M.<\/strong> A 63-Year-Old Man with Nausea, Vomiting, Orthostatic Dizziness, and Distal Limb Paresthesia. In: Zhou L, Burns D, Chunyu C. (A Case-Based Guide to Neuromuscular Pathology.) Springer, 2019.\u00a0https:\/\/www.amazon.com\/Case-Based-Guide-Neuromuscular-Pathology\/dp\/3030256812<\/a><\/p>\n

Kaku M, Berk JL<\/strong>. Neuropathy Associated with Systemic Amyloidosis. Semin Neurol<\/em>. 2019 Oct;39(5):578-588. doi: 10.1055\/s-0039-1688994. Epub 2019 Oct 22. View in PubMed<\/a><\/p>\n

A Angel-Korman<\/strong>, A Jaberi, V Sanchorawala, A Havasi<\/strong>. The utility of repeat kidney biopsy in systemic immunoglobulin light chain amyloidosis.<\/a>\u00a0Amyloid Journal 2019. 09 Oct 2019.<\/p>\n

Gopal D, Ruberg FL, Siddiqi O<\/strong> Impact of Genetic Testing in Transthyretin (ATTR) Cardiac Amyloidosis. 2019 Sep 13. doi: 10.1007\/s11897-019-00436-z View in PubMed<\/a><\/p>\n

Lilleness B, Doros G, Ruberg FL, Sanchorawala V.<\/strong> Establishment of brain natriuretic peptide-based criteria for evaluating cardiac response to treatment in light chain (AL) amyloidosis.\u00a0Br J Haematol. 2019 Sep 13. doi: 10.1111\/bjh.16198. View in PubMed<\/a><\/p>\n

Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C,\u00a0Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM. <\/strong>SNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI Expert consensus recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2 – Evidence base and Standardized methods of imaging. 2019 Aug 6.\u00a0\u00a0doi: 10.1016\/j.cardfail.2019.08.001. View in PubMed<\/a>\u00a0<\/span><\/strong><\/p>\n

Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C,\u00a0Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM<\/strong>.
\nASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization.\u00a0<\/strong>2019 Aug 6.\u00a0doi: 10.1016\/j.cardfail.2019.08.002.<\/span>\u00a0\u00a0View in PubMed<\/a><\/span><\/p>\n

Law ST, Reza Jafarzadeh S, Govender P, Sun X, Sanchorawala V, Kissin EY.<\/strong> Comparison of Ultrasound Features of major salivary glands in Sarcoidosis, Amyloidosis, and Sj\u00f6gren’s Syndrome.\u00a0Arthritis Care Res<\/em>, (Hoboken). 2019 Jul 15. View in\u00a0PubMed<\/a><\/p>\n

Staron A, Connors LH, Ruberg FL, Mendelson LM, Sanchorawala, V.<\/strong> A new era of amyloidosis: the trends at a major US referral.\u00a0Amyloid, The Journal of Protein Folding Disorders, <\/em>July 2019. View online<\/a><\/p>\n

Pudusseri A, Sanchorawala V, Sloan JM, Bever KM, Doros G, Kataria S, Sarosiek S.<\/strong> Prevalence and prognostic value of D-dimer elevation in patients with AL amyloidosis.\u00a0Am J Hematol<\/em>, 2019, Jul 11. doi: 10. 1002\/ajh.25576 [Epub ahead of print]. View online<\/a><\/p>\n

Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS.<\/strong> Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol<\/em>, 2019, June 11; 73 (22): 2872-2891. View in PubMed<\/a>.<\/p>\n

McCausland KL, Quock TP, Rizio AA, Bayliss MS, White MK, Guthrie SD, Sanchorawala V.<\/strong> Cardiac biomarkers and health-related quality of life in patients with light chain (AL) amyloidosis.\u00a0British Journal of Haematology<\/em>, 2019, 185, 940-1007. View online<\/a><\/p>\n

Sanchorawala V, Doros G, Shelton, AC.<\/strong> Long term outcome of patients treated on clinical trials of immunomodulatory agents for the treatment of AL amyloidosis: A pooled analysis.\u00a0Am J Hematol<\/em>. 2019 April 24. doi: 10. 1022\/ajh.25497. View in PubMed<\/a><\/p>\n

Morgan GJ, Yan NL , Mortenson DE, Rennella E, Blundon JM, Gwin RM, Lin CY, Stanfield RL, Brown SJ, Rosen H, Spicer TP, Fernandez-Vega V, Merlini G, Kay LE, Wilson IA, Kelly JW<\/strong>. Stabilization of amyloidogenic immunoglobulin light chains by small molecules. Proceedings of National Academy of\u00a0Sciences of the United States of America.\u00a0<\/em>2019 Apr 10. doi: 10.1073\/pnas.1817567116.\u00a0View in PubMed<\/a><\/p>\n

Ehman EC, El-Sady MS, Kijewski MF, Khor YM, Jacob S, Ruberg FL, Sanchorawala V, Landau H, Yee AJ, Bianchi G, Di Carli MF, Falk RH, Hyun H, Dorbala S.<\/strong> Early Detection of Multiorgan Light Chain (AL) Amyloidosis by Whole Body 18<\/span><\/sup>F-florbetapir PET\/CT.\u00a0<\/strong>Journal of Nuclear Medicine.\u00a06 April 2019<\/span>\u00a0<\/em>dio:10.2967\/jnumed.118.221770. View in PubMed<\/a><\/a><\/p>\n

Gupta VK, Brauneis D, Shelton AC, Quillen K, Sarosiek S, Sloan JM, Sanchorawala V.\u00a0<\/strong>Induction Therapy with Bortezomib and Dexamethasone and Conditioning with High-Dose Melphalan and Bortezomib Followed by Autologous Stem Cell Transplantation for AL Amyloidosis: Long Term Follow-Up\u00a0Analysis.\u00a0Biology of Blood and Marrow Transplantation.\u00a0<\/em>11 Jan 2019.\u00a0doi: 10.1016\/j.bbmt.2019.01.007. View in\u00a0PubMed<\/a><\/p>\n

Lilleness B, Ruberg FL, Mussinelli R, Gheorghe D, and Sanchorawala V.\u00a0<\/strong>Development and validation of a survival staging system incorporating BNP in patients with light chain\u00a0amyloidosis.\u00a0American Society of Hematology.\u00a0<\/em>17 Jan 2019, 133 (2019).\u00a0doi: https:\/\/doi.org\/10.1182\/blood-2018-06-858951. View in\u00a0PubMed<\/a><\/p>\n

Phull P, Sanchorawala V, Brauneis D, Sloan JM, Siddiqi OK, Quillen K, Sarosiek S.\u00a0<\/strong>High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators. Bone Marrow Transplantation. <\/em>21 Jan 2019.\u00a0doi: 10.1038\/s41409-019-0440-5. View in PubMed<\/a><\/p>\n

Sanchorawala V.\u00a0<\/strong>Delay treatment of AL amyloidosis at relapse until symptomatic: devil is in the details.. Blood Advances. 22 Jan 2019. doi: 10.1182\/bloodadvances.2018021261. View in PubMed<\/a><\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Staron A, Kataria Y, Murray D, Sloan J.M, Sanchorawala V.\u00a0 Systemic AL amyloidosis with an undetectable plasma cell dyscrasia: a zebra without stripes.\u00a0American Journal of Hematology. 17 Nov 2019. Sarosiek S, Sanchorawala V. Treatment Options for Relapsed\/Refractory Systemic Light-Chain (AL) Amyloidosis: Current Perspectives. J Blood Med. 2019 Oct 23; 10:373-380. View in PubMed Elliot J, […]<\/p>\n","protected":false},"author":15499,"featured_media":0,"parent":0,"menu_order":2,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages\/3705"}],"collection":[{"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/users\/15499"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/comments?post=3705"}],"version-history":[{"count":42,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages\/3705\/revisions"}],"predecessor-version":[{"id":3976,"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/pages\/3705\/revisions\/3976"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/amyloid\/wp-json\/wp\/v2\/media?parent=3705"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}